Zura Bio (ZURA) Retained Earnings (2021 - 2026)
Zura Bio (ZURA) posted quarterly Retained Earnings of -$248.8 million for Q1 2026, down 43.52% year-over-year from -$440.4 million in Q1 2025, and down 176.29% quarter-over-quarter from $326.1 million in Q4 2025.
Zura Bio (ZURA) Retained Earnings (2021 - 2026) Analysis & Trends
Zura Bio's Retained Earnings history runs 6 years deep, the most recent figure standing at -$248.8 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 43.52% year-over-year to -$248.8 million; the TTM figure through Mar 2026 stood at -$248.8 million (down 43.52% YoY), while the FY2025 annual figure was $326.1 million, up 309.16% from the prior year.
- Retained Earnings for Q1 2026 stood at -$248.8 million, down from $326.1 million in the prior quarter.
- The five-year high for Retained Earnings was $326.1 million in Q4 2025, with the low at -$248.8 million in Q1 2026.
- The 5-year median for Retained Earnings is -$41.9 million (2023), against an average of -$18.6 million.
- Peak annual rise in Retained Earnings reached 2326.23% in 2023, while the deepest fall reached 1161.01% in 2023.
- Zura Bio's Retained Earnings stood at -$32.1 million in 2022, then sank by 222.87% to -$103.5 million in 2023, then plunged by 50.63% to -$155.9 million in 2024, then surged by 309.16% to $326.1 million in 2025, then plunged by 176.29% to -$248.8 million in 2026.
- Business Quant data shows ZURA's Retained Earnings at -$248.8 million in Q1 2026, $326.1 million in Q4 2025, and -$207.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | 472.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 472.15 Mn |
| Mar 31, 2026 | -248.77 Mn |
| Dec 31, 2025 | 326.08 Mn |
| Sep 30, 2025 | -207.37 Mn |
| Jun 30, 2025 | -189.30 Mn |
| Mar 31, 2025 | -173.34 Mn |
| Dec 31, 2024 | -155.90 Mn |
| Sep 30, 2024 | 295.31 Mn |
| Jun 30, 2024 | 278.09 Mn |
| Mar 31, 2024 | -111.24 Mn |
| Dec 31, 2023 | -103.50 Mn |
| Sep 30, 2023 | 158.23 Mn |
| Jun 30, 2023 | -86.75 Mn |
| Mar 31, 2023 | -41.90 Mn |
| Dec 31, 2022 | -32.06 Mn |
| Sep 30, 2022 | -7.11 Mn |
| Jun 30, 2022 | -6.88 Mn |
| Mar 31, 2022 | -9.03 Mn |
| Dec 31, 2021 | -9.18 Mn |